Clicky

Daehan New Pharm Co. Ltd(054670)

Description: Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and animal health products in South Korea and internationally. The company offers pharmaceutical products, including cardiovascular, endocrine, neuropsychiatric, gastrointestinal, respiratory, musculoskeletal, osteoporosis, anti-cancer, urogenital, antifungal, antiviral hormone, dermatologic, central nervous, hormone, and antiobesity drugs, as well as antipyretic, analgesic, anti-inflammatory, and anti-infective drugs. It also provides antibiotics, antineoplastic, anticonvulsives, vitamins and others, amino acids, anesthetics, and inorganic products. In addition, the company offers animal health and nutrition products for poultry, cattle, sheep, swine, and fish; health supplements; and medical devices, as well as develops serum-free media for clinical application and fibroblast-based cell therapy. Daehan New Pharm Co., Ltd. was incorporated in 1984 and is headquartered in Hwaseong-si, South Korea.


Keywords: Pharmaceutical Pharmaceutical Products Drugs Medication Antibiotics Cell Therapy Nutrition Products Osteoporosis Animal Health Products Antipyretics Antifungal Inorganic Products

Home Page: www.dhnp.co.kr

66 Jeyakgongdan 1-gil
Hwaseong-si, 18622
South Korea
Phone: 82 3 1353 6141


Officers

Name Title
Mr. Geon-U Bae Chief Exec. Officer and Exec. Director
Young-Jun Song VP and Exec. Director

Exchange: KQ

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0.741
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks